Background and Purpose-Treatment options for patients with acute ischemic stroke depend on the volume of salvageable tissue. This volume assessment is currently based on fixed thresholds and single imagine modalities, limiting accuracy. We wish to develop and validate a predictive model capable of automatically identifying and combining acute imaging features to accurately predict final lesion volume. Methods-Using acute magnetic resonance imaging, we developed and trained a deep convolutional neural network (CNN deep ) to predict final imaging outcome. A total of 222 patients were included, of which 187 were treated with rtPA (recombinant tissue-type plasminogen activator). The performance of CNN deep was compared with a shallow CNN based on the perfusion-weighted imaging biomarker Tmax (CNN Tmax ), a shallow CNN based on a combination of 9 different biomarkers (CNN shallow ), a generalized linear model, and thresholding of the diffusion-weighted imaging biomarker apparent diffusion coefficient (ADC) at 600×10 −6 mm 2 /s (ADC thres ). To assess whether CNN deep is capable of differentiating outcomes of ±intravenous rtPA, patients not receiving intravenous rtPA were included to train CNN deep, −rtpa to access a treatment effect. The networks' performances were evaluated using visual inspection, area under the receiver operating characteristic curve (AUC), and contrast. 
T he progression of ischemic stroke is highly complex and individual. However, although advanced magnetic resonance (MRI) or computed tomographic (CT) imaging hold much potential, these modalities are often used only to measure the volume of tissue exceeding fixed uniform thresholds for hypoperfusion and tissue damage. 1, 2 With MRI, tissue is commonly considered irreversibly damaged if the apparent diffusion coefficient (ADC) calculated from diffusion-weighted imaging (DWI) is <600×10 −6 mm 2 /s 2 . Similarly, tissue exceeding 6 seconds on the time point for the maximum of the residue function (Tmax) image derived from MRI or CT perfusion-weighted imaging (PWI) is considered at risk of infarct. 2, 3 Thresholdbased relations between compromised blood delivery and later infarct can be traced at least back to positron-emission tomography and electroencephalography studies by Astrup et al 4 in animals and humans. They proposed using the volume of the so-called ischemic penumbra as a treatment target in acute stroke. Summarizing earlier studies, Astrup et al 4 note that neuronal electrical activity vanishes around a blood flow of 16.0 mL/g per minute, whereas irreversible chronic infarction develops in areas with a blood flow <10.0 mL/g per minute, which is likely because of energy and ion pump failure. Thresholds on CT-and MRI-based imaging biomarkers may be considered modern instrumentations of these concepts.
The uniform thresholding approach suffers from several shortcomings. First, stroke progression is highly heterogeneous and probably defies population-based thresholds in imaging biomarkers. Second, thresholding represents a static model without the capacity to adapt as new data become available in the clinic or from trials. Third, thresholding does usually not encompass the broad information range obtainable from, primarily, PWI scans, which may hold further clues to tissue progression. Considering the small difference in blood flow rate between electrical silence and energy failure, supportive information from blood volume, capillary transit times, and oxygen availability markers 5 is highly desirable. Fourth, the indirect assessment of the ischemic penumbra offered by PWI measurements is potentially limited to the value and confidence afforded by individual metrics. Fifth, the dichotomous nature of the tissue categorization into irreversibly damaged or potentially salvageable tissue is likely too simplistic and certainly lacks reflection on the certainty level.
The volume and location of the final infarct depend on a complex interplay between many tissue characteristics and clinical characteristics, of which probably only a few have been studied. Simultaneous inclusion of multiple modalities into 1 model has primarily been attempted through generalized linear models (GLMs), 6, 7 where tissue categorization predictions are offered based on several input maps. The GLM approach overcomes the thresholding methods' shortcomings and is capable of incorporating voxel-wise information from multiple input channels but neglects spatial information. Aiming to increase predictive accuracy, we set out to develop a statistical model capable of better integrating all available imaging information from the individual patient in a spatial manner.
In the present work, we apply a convolutional neural network (CNN) 8 to MRI data to predict tissue outcome. The CNNs accommodate stroke heterogeneity from databases containing information on tissue outcome from previous patients and have potential to increase predictive ability with additional patients. Additionally, CNN has the advantage of including simultaneously both multiple input biomarkers and spatial information and being capable of modeling complex interplays between the input images. The spatial information inclusion and complex interplay modeling is the main difference compared with the GLM, making CNNs less sensible to noise and artifacts and providing CNNs with the ability to learn more from the data. Furthermore, the predictive results from CNNs yield an infarction probability providing a muchneeded certainty level, and CNN is thus a suitable candidate for stroke progression assessment. A few attempts have been made to use the technology in ischemic stroke lesion segmentation, [9] [10] [11] but the use of CNNs for final infarct prediction of acute ischemic stroke is limited. 12, 13 We implemented 3 different CNNs in this study. First, as an alternative to Tmax thresholding, 2 a CNN based on the Tmax imaging biomarker (CNN Tmax ) 13 was applied to use spatial information from Tmax, while simultaneously learning to detect false-positive regions. Second, a simple CNN (CNN shallow ), taking 9 MRI biomarkers into account, was developed to use available information from MRI scans. Finally, a deep CNN (CNN deep ), which is a modified version of SegNet, 14 using 9 MRI biomarkers was implemented to account for the biomarkers' complex interplay and their role in stroke development. The performance of the networks is compared with a GLM 6, 7 and thresholding of the ADC biomarker at 600×10 
Materials and Methods

Patients and Image Acquisition
Because of the sensitive nature of the data and compliance regulations pertaining to general data protection regulation, requests to access the data set from qualified researchers trained in human subject confidentiality protocols may be sent to Aarhus University at leif@ cfin.au.dk and grethe.andersen@clin.au.dk. In this retrospective study, 222 patients (91 women) from the I-KNOW multicenter (105) [15] [16] [17] and remote ischemic perconditioning (117) 18,19 studies were analyzed. Patients were admitted with symptoms consistent with acute ischemic stroke and triaged with MRI for intravenous rtPA (recombinant tissuetype plasminogen activator). Patient characteristics are summarized in the Table. Included were all patients with acute DWI, acute PWI, acute T2-weighted fluid-attenuated inversion recovery (T2-FLAIR), and follow-up T2-FLAIR. The main focus was to predict imaging outcome in the subgroup of patients receiving intravenous rtPA (n=187). The 35 untreated patients were used to assess the algorithm's ability to identify treatment-based differences in disease progression by posttraining of CNN deep . The original clinical studies were conducted in accordance with the Helsinki declaration and approved by local ethics committees. All patients gave written informed consent. Subsequent data usage for the purpose of retrospective studies, such as ours, was included in the original study protocols. [16] [17] [18] 20 The acute imaging protocols included standard gradient-echo dynamic susceptibility contrast PWI MRI, T2-FLAIR, and DWI MRI. The dynamic susceptibility contrast PWI sequence was acquired during intravenous gadolinium-based contrast injection (0.1 mmol/kg at rate 5 mL/s) followed by 30 mL physiological saline (injected at rate 5 mL/s). Echo-planar DWI was obtained at magnetic field strengths of b=0 s/mm 2 and b=1000 s/mm 2 . The nonzero images were acquired at 3 to 12 directions, depending on the scanner/vendor type at the admitting hospital (GE: Signa Excite 1.5T, Signa Excite 3T, Signa HDx 1.5T, Signa Genesis 1.5T [Milwaukee, WI]; Siemens: TrioTim 3T, Avanto 1.5T, Sonata 1.5T [Erlangen, Germany]; Philips: Gyroscan NT 1.5T, Achieva 3T, Intera 1.5T [Best, the Netherlands]). Further details on the imaging parameters are provided in the study by Hansen et al 21 and Table I in the online-only Data Supplement.
Imaging Modalities
The following maps were derived from the perfusion data: mean capillary transit time, cerebral blood volume, cerebral blood flow, cerebral metabolism of oxygen 22 , relative transit time heterogeneity, delay, and Tmax. The perfusion preprocessing steps, consisting of motion DWI indicates diffusion-weighted imaging; Max, maximum; Min, minimum; MRI, magnetic resonance imaging; NIHSS, National Institutes of Health Stroke Scale; PWI, perfusion-weighted imaging; SNR, signal-to-noise ratio; and T2-FLAIR, T2-weighted fluid-attenuated inversion recovery.
correction, arterial input function selection, and calculation of perfusion maps, were done using the PENGUIN perfusion analysis software (www. cfin.au.dk/software/pgui). The arterial input function was initially identified automatically by the software 23 and then examined and adjusted, if necessary, by an expert neuroradiologist. Mean capillary transit time and cerebral blood flow were computed using a parametric deconvolution 5, 24 of the concentration curve. In addition, the imaging biomarkers cerebral metabolism of oxygen and relative transit time heterogeneity were computed using a procedure 5, 24 based on a vascular model 22 of capillary transport and oxygen availability, which have previously been hypothesized to contribute to the characterization and prognosis of acute ischemic stroke. 15, 25 The temporal difference between site of measurement of the tissue concentration curve and the arterial input function, the bolus delay, was estimated directly by the vascular model and represented with oscillation index singular value decomposition 26 as the Tmax map. The DWI and T2-FLAIR images were linearly coregistered and resliced to acute PWI space using a 12-parameter affine transformation with a normalized mutual information cost function, as implemented in the Statistical Parametric Mapping v. 8 (SPM 8; Wellcome Trust Centre for Neuroimaging, London, United Kingdom) toolbox.
An average DWI image (TRACE DWI) was obtained from the DWI sequence by averaging overall b=1000 s/mm 2 images and used in conjunction with the b=0 s/mm 2 image to obtain an ADC image. 2 The PWI, DWI, and T2-weighted fluid-attenuated inversion recovery values were normalized to normal-appearing contralateral white matter to facilitate comparison across subjects.
Prediction of Imaging Outcome
A CNN consists of layers with different properties, which are connected according to a network architecture (an example is shown in Figure 1 ). In general, with more layers in a network (the deeper the network is), the network is able to recognize more complex structures. We developed CNN deep to predict stroke imaging outcome based on SegNet 14 with mean capillary transit time, cerebral blood volume, cerebral blood flow, cerebral metabolism of oxygen, relative transit time heterogeneity, delay, TRACE DWI, ADC, and T2-FLAIR biomarkers as input.
To assess whether high performance shown by CNN deep was caused by the inclusion of spatial information, a CNN with a few layers (shallow), called CNN shallow , taking the same input as CNN deep was implemented.
The Tmax biomarker has been used in clinical trials for patient triaging and is believed to have a strong association with final outcome. 2, 3, 27 Therefore, CNN Tmax was implemented to evaluate whether Tmax contains sufficient information to make accurate predictions, if spatial information was included and the tissue predictions were not restricted to using a single population-wide threshold. CNN Tmax is based on previously published work by Stier et al 13 and is reconstructed as close to their reported implementation as possible.
The CNNs were compared with a regression approach, which in a simple linear fashion combines biomarkers to predicted risk of infarct at the level of single voxels using a GLM. 6, 7 Thresholding of the ADC biomarker at 600×10 −6 mm 2 /s (ADC thres ) was used to estimate the final infarct of patients treated with intravenous rtPA. 2 Implementation-relevant details are stated in the online-only Data Supplement.
The CNN was trained using TensorFlow 28 with Python 2.7 29 interface. Once a network is trained, risk maps for a new patient are obtained in ≈60 seconds. The training of the networks, which needs only to be done once, took around 5 days for CNN deep and less than a day for the other CNNs on a standard work station with an NVIDIA Quadro K2200 GPU with 4GB memory. The statistical analyses were performed using R, version 3.2.3.
30
Statistical Analysis Performance Evaluation
The 187 patients who received intravenous rtPA treatment were randomly divided into independent training set (158 patients) and test set (29 patients) using an 85/15 split, thus allowing assessment of model performance in independent patients, unknown to the models during training. The training process was monitored using independent validation patches, to prevent overfitting. The online-only Data Supplement contains further details on data sampling. The follow-up infarcts were independently delineated by 4 expert radiologists on the follow-up T2-FLAIR scan (demonstrated to minimize interrater variability 31 ) acquired 1 month after the stroke. The delineations were performed using an in-house developed software. The raters worked independently and were blinded to patients' clinical data and any results from automated delineation methods. A consensus degree of 3 was used to determine a common final infarct. 21 The predictive performance was evaluated using the area under the receiver operating characteristic curve (AUC), calculated following Jonsdottir et al. 32 The AUC has the advantage of being threshold independent and can be interpreted as the probability of an infracting voxel receiving a higher risk score than a noninfarcting. The contrast is measured as 1 minus the mean of the predicted risks of infarcting for voxels outside the final infarct. The calculated AUC and contrast metrics were pairwise compared through paired t tests. Please note that AUC and contrast values are presented as mean±SD.
Treatment Effect
To assess the effect of the intravenous rtPA treatment, the weights from CNN deep were used as a starting point for posttraining on 35 untreated patients, resulting in CNN deep, −rtpa . The 29 intravenous rtPA-treated patients in the test set were then evaluated using the new model. The AUC and the size of the final infarct (stated as [mean (min-max)]) were compared. This approximation of treatment effect is the same approach used by Wu et al. infarct risk. The rightmost column shows the T2-FLAIR follow-up scan with the manually delineated infarcted tissue as a contour. The examples overall display that GLMs' and ADC thres s' voxel-wise predictions lead to scattered risk maps compared with the CNN-based methods. The CNN-based methods generally outperform other methods in producing spatially coherent lesion estimates, albeit considerable differences in accuracy are observed.
CNN shallow tends to overestimate the final lesion volume, and CNN Tmax predicts low infarct risk, which is also not well aligned with the actual outcomes. CNN deep provides visually superior predictions compared with the other models. Of particular interest is patient A-a 58-year-old man-who did not have any visible lesion at follow-up, which is correctly predicted by CNN deep , whereas the other methods substantially overestimate the permanent lesion. Figure 3A shows box plots of AUCs for each predictive model for the 20 test set patients with a final infarct. The highest AUC was obtained for CNN deep (0.88±0.12), followed by CNN shallow (0.85±0.11), GLM (0.78±0.12), CNN Tmax (0.72±0.14), and ADC thres (0.66±0.13). A significant difference was shown between CNN deep and GLM (P=0.005), CNN Tmax (P<0.003), and ADC thres (P<0.0001). The difference was not significant (P=0.063) for CNN deep and CNN shallow , despite substantial difference in visual appearance as demonstrated in Figure 2 . The test also yielded a significant difference between CNN shallow and GLM (P=0.013), CNN Tmax (P<0.005), and ADC thres (P<0.0001). Thus, the CNNs with many biomarkers as input lead to superior performance measured by AUC. Figure 3B shows box plots of the image contrast. For CNN deep , the contrast was (0.99±0.02), followed by CNN shallow (0.88±0.04), CNN Tmax (0.95±0.01), GLM (0.96±0.04), and ADC thres (0.88±0.19). Hence, CNN shallow and ADC thres had a lower mean contrast compared with CNN deep , CNN Tmax , and GLM, which was consistent with the high infarction risk in areas outside the final infarct observed in Figure 2 . Indeed, pairwise paired t tests showed a significant difference between CNN shallow and CNN deep , CNN Tmax , and GLM (P<0.0001). A significant difference was also found between CNN deep and CNN Tmax and GLM (P<0.0001). ADC thres was significantly inferior to CNN deep (P=0.004) and GLM (P=0.026), but not to CNN Tmax (P=0.058). 
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Treatment Effect
AUC for the intravenous rtPA-treated test patients evaluated using CNN deep, −rtPA was 0.85±0.15. This is not significantly lower than AUC for CNN deep (P=0.16), and hence, if the desired outcome is a difference in AUC, there appears to be no compelling reason to train a network specifically for nonrtPA-treated patients. However, Figure 4 shows 2 patient cases of which the first patient-a 58-year-old man-presents different DWI/PWI lesions. According to the penumbra model, this would suggest a large treatment effect. This supposition is accurately picked up by the substantial treatment effect predicted by CNN deep . Conversely, the DWI/PWI lesions are similar for the second patient-a 65-year-old man-leading to almost no treatment effect, consistent with the penumbra model. As one might expect, the mean volume of the infarcted areas was lower (16.44 
Discussion
We hypothesized CNN deep to yield superior results compared with the other methods. Our analysis showed CNN deep to be able to use information from the acute images and transform them into accurate predictions of final outcome. In independent test data, the performance of CNN deep , as measured by AUC, is highly concordant with the actual outcome, assessed by follow-up T2-FLAIR images, and superior compared with shallow networks and voxel-based approaches. This is confirmed by visual inspection. A clear contrast between final infarct and voxels outside the infarction in the risk map is crucial, as the image becomes easier to interpret. Contrast-wise, CNN deep was significantly better than the other methods. The treatment effect was slightly significant with no intravenous rtPA, yielding a higher volume of final infarct.
We think that the superior performance observed for CNN deep is rooted in better utilization of the information encoded in data from previous patients. During the training process, the model self-regulates, while simultaneously incorporating the heterogeneity of the stroke progressions. This is exemplified by the predicted CNN deep risk maps in Figure 2 , showing a fairly high prediction certainty in terms of infarction risk.
CNN deep model is capable of retaining and processing complex information and thereby discover a more accurate connection between the input and the output, considering the heterogeneity in stroke pathophysiology. This enables CNN deep to predict the final outcome more accurately in an automatic and user-independent manner, and we speculate that the predictions may improve by incorporating additional data in subsequent model training.
During the training process, a CNN extracts important features in a data-driven fashion, whereas these features have to be handcrafted for the GLM.
Although the results presented here show that CNN deep predicts final outcome accurate, there is a need for external validation of the model's applicability in a clinical setting. An important first step would be to test the model on a data set from another clinical study to assess generalizability. 1 These methods use different imaging biomarkers but are all limited to 2. Our analysis shows ADC thresholding to be insufficient, which might be because of an interplay between tissue characteristics not captured by a single biomarker.
We decided to assess the ability of the CNN to identify treatment differences based on whether or not the patients received intravenous rtPA treatment. The same methodology could equally well be used to examine the direct effects of recanalization. Here, we took ±intravenous rtPA to avoid the need to handle partial recanalization, which would have limited our data volume.
A considerable data volume representing actual clinical variability is necessary for any method attempting to uncover and harness the complex relation between acute and follow-up imaging in acute stroke. In our opinion, it is pivotal to gather all possibly available information to achieve the best predictions. Therefore, we decided to sample from all slices in the training data ensuring a balanced data set, which hopefully influences positively on the generalization of CNN deep . This is in contrast to the study by Stier et al, 13 where only the slices with the largest lesion were selected, discarding information from the remaining imaging voxels. In our view, this approach disregards the infarct heterogeneity and how different parameters react in the presence of ischemia.
One important difference between GLM and CNN is GLM being a voxel-by-voxel-based technique. The CNNs include spatial information by allowing 2-dimensional images as input. We speculate that this is one of the key differences, giving CNN an advantage simply by having spatial information available and thereby making the predictions less sensitive to noisy data.
We chose to use the performance measure presented by Jonsdottir et al 32 to evaluate the performance of the predictions. This approach ensures a threshold-independent measure (as opposed to measures, such as DICE coefficient or accuracy) and emphasizes the performance of tissue infarction risk inside the hypoperfused tissue.
Limitations
The data used in this study were retrospectively acquired. To mimic a prospective study, we divided the data and used some of the patients for testing only. However, because the data are not collected to improve our predictive model's performance, there might be a variation in new patients not included in the current data. A further drawback might be the fact that we included patients scanned with a variety of scanners, scan parameters, and field strengths, which introduces uncontrollable sources of data material variation. However, even with these challenges, CNN deep yielded good results, which in our view speaks to the generalization and robustness of CNN deep .
All our patients experienced an acute ischemic stroke, thereby effectively omitting a control group from the study and introducing a risk of being biased toward infarct overestimation. However, the data set contained numerous slices with normoperfused voxels, and the predictive models effectively classified those accordingly. We think this constitutes a robust approach, with overestimation bias being likelier in the training data preparation method used by Stier et al. 13 One drawback of CNN methods is the training time. The training time is related to the complexity of the network and becomes more pronounced with deeper networks. However, it is only necessary to train the network once, and the evaluation of a new patient takes ≈1 minute. Another drawback of the CNN method is the amount of training data needed. Without sufficient training data, the CNN is prone to overfitting, and CNN deep is the most vulnerable because it contains more parameters. We mitigated this by following the standard machine learning procedure and evaluated the models' performance on an independent test set. Furthermore, we trained the networks using mini-batch stochastic gradient descent to stabilize the training process and avoid too much adaption to the training set. We suspect the performance of the CNN-based methods in general, and CNN deep in particular will increase with more training data.
In this article, we found a treatment effect measured by final infarct volume, although the effect was small for most patients. It could be speculated whether the network underestimates the treatment effect. However, the intravenous rtPA treatment effect is time dependent, expected to be smaller than the effect of thrombectomy, and not guaranteed to lead to reperfusion. Additionally, a minor treatment effect would be expected if the DWI/PWI mismatch is small, according to the penumbra model. Therefore, we find it encouraging that the network was able to detect the small treatment effect. However, the data set is relatively small, and further validation before clinical use is required.
Different end points can be considered in stroke prediction. Here, we chose to use imaging outcome because this is a high-resolution representation of stroke outcome and, therefore, a demanding task. Functional outcome could be an alternative, however, that would reduce the follow-up information available per patient (from voxels to a single score). Moreover, functional outcome might even be obtainable via the predicted risk map. One issue concerns how to establish the outcome reference. We chose to apply a consensus decision of at least 3 of 4 expert neuroradiologists using followup T2-FLAIR images to minimize interrater variability 21, 31 to mitigate this problem.
Conclusions
The comparison of predictive models described in this article shows a clear advantage of using a deep CNN, such as CNN deep , to produce predictions of final infarct in acute ischemic stroke.
A CNN has the advantage of being able to retain spatial information, resulting in more accurate predictions compared with a GLM-based model. The depth of the CNN is important, with many layers in the network yielding a better contrast and a higher accuracy of the predicted images.
The new model paradigms have been shown to lead to improved predictions and thereby a much increased potential for use in automated decision support systems providing recommendations for personalized treatment and thereby hopefully better outcome for the individual patient. CNNs will likely benefit from increasingly larger image collections, in contrast to less-complex methods, such as GLM and population-wide thresholds, which lack the information-encoding capabilities of CNNs. An advantage of CNNs is its ability to learn and become progressively better with every new patient.
